Efectos adversos del tratamiento farmacológico del tabaquismo

266
Efectos adversos del tratamiento farmacológico del tabaquismo
25. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: Implications for
nicotine replacement therapy. J Am Coll Cardiol 1997; 29: 1422-31.
26. Associated Press. Nicotine patches´ link to heart attacks probed. Safety of smoking
during use questioned. The Washington Post, June 20, 1992.
27. Working Group for the Study of Transdermal Nicotine in Patients with Coronary
Artery Disease. Nicotine replacement therapy for patients with coronary artery disease.
Arch Intern Med 1994; 154: 989-95.
28. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG et al.
The safety of transdermal nicotine as an aid to smoking cessation in patients with
cardiac disease. N. Engl J Med 1996; 335: 1792-8.
29. Homsy W, Yan K, Houle JM, Besner JG, Gossard D, Pierce CH. Plasma levels of nicotine
and safety of smokers wearing transdermal delivery systems during multiple
simultaneous intake of nicotine and during exercise. J Clin Pharmacol 1997; 37:
728-36.
30. Hjalmarson A, Franzon M, Westin A, Wiklund O. Effect of nicotine nasal spray on
smoking cessation. A randomized, placebo-controlle, double-blind study. Arch Intern
Med 1994; 154: 2567-72.
31. Hurt RD, Dale LC, Croghan GA, Croghan IT, Gómez-Dahl LC, Offord KP. Nicotine
nasal spray for smoking cessation: Pattern of use, side effects, relief of withdrawal
symptoms, and cotinine levels. Mayo Clin Proc 1998; 73: 118-25.
32. Nicotine spray nasal (Nicotrol ® NS). En: Physicians’ Desk Reference, 56th ed. Montvale,
NJ: Medical Economics Company, 2002; 2843-6.
33. Quinn DI, Wodak A, Day RO. Pharmacokinetic and pharmacodynamic principles
of illicit drug use and treatment of illicit drug users. Clin Pharmacokinet 1997;
33: 344-400.
34. Setter SM, Johnson MD. Transdermal nicotine replacement smoking cessation therapy.
Ann Pharmacother 1998; 32: 264-6.
35. Goldstein MG, Niaura R. Methods to enhance smoking cessation after myocardial
infarction. Med Clinics North Am 2000; 84: 63-80.
36. Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation
to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention
Trial (MRFIT). Am J Public Health 1990; 80: 954-8.
37. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation
and hemostatic function: Comparison of transdermal nicotine and cigarette
smoking. J Am Coll Cardiol 1993; 22: 1159-67.
38. Benowitz NL. Nicotine replacement therapy during pregnancy. JAMA 1991; 266:
3174-7.
39. Walsh RA, Lowe JB, Hopkins PJ. Quitting smoking in pregnancy. Med J Aust 2001;
175: 320-3.
40. Oncken CA, Hatsukami DK, Lupo VR, Lando HA, Gibeau LM, Hansen RJ. Effects of
short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther 1996;
59: 654-61.
41. Wright LN, Thorp JM, Kuller JA, Shrewsbury RP, Ananth C, Hartmann K. Transdermal
nicotine replacement in pregnancy: Maternal pharmacokinetics ad fetal effects.
Am J Obstet Gynecol 1997; 176: 1090-4.